1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Global H1N1 Vaccines Market 2016-2020

Global H1N1 Vaccines Market 2016-2020

  • June 2016
  • -
  • Infiniti Research Limited
  • -
  • 83 pages

Summary

Table of Contents

Search Inside

About the H1N1 Vaccines Market

The high level of maturity in the H1N1 vaccines market has renewed the push to develop quadrivalent vaccines that address areas of the market with unmet medical needs. Vaccines that prevent H1N1 have been a long-standing void in the treatment algorithm. Therefore, the introduction advanced vaccines in the next decade will likely alter the global H1N1 vaccines market landscape. Sanofi, AstraZeneca, and VaxInnate have also invested in quadrivalent vaccines, such as Sanofi's VaxiGrip, VaxInnate's VAX2012Q, and AstraZeneca's MEDI-550 vaccine, which will impact the US and Europe markets during the forecast period. Other areas of opportunity for novel entrants include vaccines with improved immune response and immunogenic infant vaccines.

Technavio’s analysts forecast the global H1N1 vaccines market to grow at a CAGR of 4.17% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global H1N1 vaccines market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of vaccines used to prevent H1N1 infection. The report also considers the revenues to be generated from the sales of vaccines that are expected to be launched into the market during the forecast period.


The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, Global H1N1 Vaccines Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendorsoperating in this market.

Key vendors
- Sanofi
- GSK
- Astra Zeneca
- CSL


Other prominent vendors
- Abbott
- Baxter International
- CEL-SCI
- Cipla
- Crucell
- Denka Seiken
- Green Cross
- Hualan Biological Engineering
- iBio
- Imunoloski Zavod
- Inovio Biomedical
- Lupin
- Medicago USA
- Merck
- Mitsubishi Tanabe Pharma
- Omnivest
- Panacea
- Pfizer
- Protein Sciences
- Serum Institute of India
- Sinovac Biotech
- Solvay
- Zhejiang Tianyuan Bio-pharmaceuticals
- Zydus Cadila

Market driver
- Global action plan for influenza vaccines
- For a full, detailed list, view our report

Market challenge
- Vaccine storage and handling issues
- For a full, detailed list, view our report

Market trend
- Improved understanding of immunology
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.



Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
The Global Influenza Market

The Global Influenza Market

  • $ 6650
  • Industry report
  • March 2017
  • by BCC Research

Use this report to: - Receive an overview of products currently in the marketplace and a detailed analysis of market position and competitive environments. - Identify the markets in general segments: ...

Influenza Diagnostics Market by Test type, Molecular, End user - Global Forecast to 2021

Influenza Diagnostics Market by Test type, Molecular, End user - Global Forecast to 2021

  • $ 5650
  • Industry report
  • February 2017
  • by MarketsandMarkets

The global influenza diagnostics market is expected to reach USD 767.4 million by 2021 from USD 508.0 million in 2016, at a CAGR of 8.6% from 2016 to 2021. On the basis of test type, the market is segmented ...

Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies

Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies

  • $ 4995
  • Industry report
  • January 2017
  • by GBI Research

Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies Summary Seasonal influenza is a viral ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.